Document is current

Any future updates will be listed below

Correction: Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study

Crossref DOI link: https://doi.org/10.1007/s00592-025-02482-7

Published Online: 2025-03-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark